SCI Logo
 

SCI Publications

Username:
Password:

 
 
Click here to go to the Chemistry & Industry web site
 
Click here to go to The SupplyLine web site
 
Click here to go to the Journal of the Science of Food and Agriculture web site
 
Click here to go to the Polymer International web site
 
Click here to go to the Pest Management Science web site
 
Click here to go to the Journal of Chemical Technology and Biotechnology web site
 
Click here to go to the Biofuels, Bioproducts and Biorefining (Biofpr) web site
 
 

Search SCI

Advance Search


Related Links
Publications Homepage

SCI Books


Bioactive Compound Design: Possibilities for Industrial Use

SCI Books from Bios Scientific Publishing
ISBN: 1-85996-165-7
Edited by M.G. Ford, R. Greenwood, G.T. Brooks and R. Franke*
University of Portsmouth, UK; and *Basdorf, Germany
1996
Paperback, 186 pages
approx £35.00



The search for novel, biologically active materials is a major goal of many of the biotechnology based industrial companies. These include pharmaceutical, agrochemical and food companies seeking new drugs, pesticides, flavours and aromas. In the past, the process of identifying new compounds has been based on low throughput biological screening of compounds developed and synthesised by organic chemists using traditional procedures. Although many valuable products have resulted from this approach, recent developments in information technology, mathematical algorithms and robotics appear to offer alternative approaches which may eventually prove to be more cost-effective. Bioactive Compound Design describes the impact that these new design procedures are having on the discovery process.

The text begins with a review of computer-aided drug design which offers tantalising insights into the potential of the methods, but also provides examples to warn the would-be practitioner of the many pitfalls which await an unsuspecting enthusiast. The book is then divided into five sections dealing respectively with:

  • Biological testing: approaches to screening
  • Lead generation
  • Chemometric methods in drug design and series optimization
  • Application of QSAR and pharmacokinetic models
  • Prediction and analysis of biological and environmental effects of compounds

Topics include the impact of high-throughput screens on the process of synthesising candidate drugs and agrochemicals for industry, the role of molecular similarity and database searching in identifying new starting structures, and the use of IT techniques such as artificial neural networks, computer modelling and expert system. These developments are illustrated by selected examples taken principally from the fields of drug and agrochemistry. The chapters by experts from both academia and industry are authoritative, contemporary and relevant to the needs of the industrial scientist.

Readership: Postgraduates and researchers; particularly in the pharmaceutical industry.


Contents
  • Computer-aided drug design: facts and fictions - H Kubinyi

Biological testing: approaches to screening

  • The use of in vitro and in vivo bioassays to screen for novel agrochemicals: approaches to experimental design - MR Bartley and D Youle
  • Screening and rational drug design - competitive or complemetary? - RM Hyde and A Hersey
  • PASS: Computerized prediction of biological activity spectra for chemical substances - DA Filimonov and VV Poroikov

Lead generation

  • The role of molecular similarity in lead generation - PM Dean et al
  • Flexible three-dimensional database searching for the identification of novel lead compounds - PW Finn and M Snarey
  • The histamine H2 receptor as a tool for medicinal chemists - PHJ Nederkoorn et al

Chemometric methods in drug design and series optimization

  • Chemometric methods in drug design: tale or tool? - R Franke
  • Artificial neural networks as an alternative to statistics - DJ Livingstone and MG Ford
  • Computer assisted drug design and biotechnology: a case study on lead optimization related to breast cancer therapy - S Nilsson and U Norinder
  • The role of binding studies in the design of bioactive molecules - K Shrimanker
  • Non-peptide angiotensin II receptor antagonists: PCA and PLS analyses employing different types of 3D molecular descriptors - M Mabilia and E Fioravanzo

The application of QSAR and pharmacokinetic models

  • Drug-membrane interaction and accumulation, conformation, efficacy and resistance - JK Seydel et al
  • Physiologic based pharmacokinetic modelling and QSAR - DE Leahy et al

Prediction and analysis of biological and environmental effects of compounds

  • Artificial intelligence: the use of computer methods in the prediction of metabolism and toxicity - CA Marchant and RD Combes
  • Environmental early-warning methods for synthesis teams - PH Nicholls
  • On the necessity of multivariate statistical tools for modeling biodegradation - J Devillers

Please send orders to:

BIOS Scientific Publishers Ltd
9 Newtec Place
Magdalen Road
Oxford
OX4 1RE

T: +44 (0) 1865 726286
Editorial & Production F: +44 (0) 1865 200386
Sales & Marketing: +44 (0) 1865 246823
W: www.BIOS.co.uk


For more information on SCI Pubiications, please contact:
Gaynor Redvers-Mutton, Publications Liaison Manager, T: +44 (0)20 7598 1554 , F: +44 (0)20 7598 1545, E: gaynor.redvers[ at]soci.org